ATAI Life Sciences BV Financial Flexibility Index
ATAI Life Sciences BV financial flexibility index. ATAI Life Sciences BV (ATAI) has a Financial Flexibility Index of -0.32x as of March 2026. Free cash flow of $-21.09 Million (operating CF $-21.09 Million minus capex $0.00) represents 0% of total liabilities ($66.10 Million). See ATAI Life Sciences BV (ATAI) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ATAI Life Sciences BV (2019–2025)
Financial flexibility index of ATAI Life Sciences BV from 2019 to 2025. Historical Financial Flexibility Index trend for ATAI Life Sciences BV across 7 annual periods. Check ATAI Life Sciences BV (ATAI) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
ATAI Life Sciences BV Financial Flexibility Index by Year (2019–2025)
ATAI Life Sciences BV financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for ATAI Life Sciences BV. For the full cash flow conversion analysis, see ATAI operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.15x | $-101.77 Million | $-102.67 Million | $88.54 Million | ▲ +40.2% |
| 2024 | -1.92x | $-82.34 Million | $-82.44 Million | $42.83 Million | ▼ -13.1% |
| 2023 | -1.70x | $-83.53 Million | $-84.12 Million | $49.16 Million | ▲ +34.8% |
| 2022 | -2.61x | $-103.44 Million | $-104.47 Million | $39.67 Million | ▼ -18.4% |
| 2021 | -2.20x | $-62.12 Million | $-63.25 Million | $28.21 Million | ▼ -72.1% |
| 2020 | -1.28x | $-20.71 Million | $-20.77 Million | $16.18 Million | ▲ +61.8% |
| 2019 | -3.35x | $-7.83 Million | $-7.85 Million | $2.34 Million | — |